RGNT — REGENTIS BIOMATERIALS LTD.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1912966 ·
Israel
Last close
$1.74
Market Cap
$12.22M
52W High
$15.50
52W Low
$1.23
ADV30
241,782
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 7,618,000 | 7,378,000 | 2,874,000 |
| Jun 2025 | — | — | — | — | 475,000 | 189,000 | 44,807,000 |
| Dec 2024 | — | — | — | — | 482,000 | 229,000 | 41,586,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-55,794,000
Inventory
—
Receivables
$230,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -8,619,000 | -13,648,000 | 7,618,000 | 2,874,000 | — | -1,375,000 |
| Dec 2024 | 0 | 932,000 | 4,801,000 | 482,000 | 41,586,000 | — | -641,000 |
| Dec 2023 | 0 | -1,931,000 | -4,132,000 | 360,000 | 46,265,000 | — | -1,220,000 |
| Dec 2022 | 0 | -1,407,000 | -1,449,000 | 1,717,000 | 43,778,000 | — | -1,504,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICU | SeaStar Medical Holding Corp | $12.51M | $3.13 | — |
| UEEC | United Health Products, Inc. | $12.71M | $0.05 | — |
| DROR | Dror Ortho-Design, Inc. | $11.63M | $0.01 | — |
| MODD | Modular Medical, Inc. | $12.94M | $2.39 | — |
| ALRTF | ALR Technologies SG Ltd. | $11.42M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C
2026-07-30 19:30 · Yahoo
Regentis Biomaterials (RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market
2026-07-27 19:00 · Yahoo
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
2026-07-20 13:00 · Yahoo
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
2026-07-16 15:30 · Yahoo
Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch
2026-07-15 13:00 · Yahoo
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
2026-06-18 01:05 · Yahoo
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
2026-06-16 18:00 · Yahoo
Why Did RGNT Stock Surge More Than 850% Today?
2026-06-15 18:06 · Yahoo
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC
2026-06-08 19:30 · Yahoo
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
2026-06-08 12:32 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.